Carregant...
Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging
Patients with schizophrenia self-administer nicotine at rates higher than is self-administered for any other psychiatric illness. Although the reasons are unclear, one hypothesis suggests that nicotine is a form of ‘self-medication’ in order to restore normal levels of nicotinic signaling and target...
Guardat en:
| Publicat a: | J Psychopharmacol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963521/ https://ncbi.nlm.nih.gov/pubmed/28441884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881117705071 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|